Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 915

Страница 1 из 92

Review of Small Molecule Anticancer NF-κB Inhibitors
agammaglobulinemia tyrosine kinase

2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma tyrosine kinases (RTKs). We report herein the synthesis of 23 arylhydrazones of active methylene compounds

Is up-regulation gene expression of the certain genes during the viral respiratory tract infection would have any influence in pathogenesis of the SAR-CoV-2 infection?receptor type tyrosine protein phosphatase C

RET/PTC3 Rearrangement in Papillary Thyroid Carcinoma: Possible Marker of Tumor Progressionprotein tyrosine kinase

A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma. The model is used to explore the combined effects of a tyrosine-kinase inhibitor (TKI) with a pentose

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors understanding of cancer biology leading to development of new targeted therapies including tyrosine kinase

The specific features of a response to a tyrosine kinase inhibitor against different histological types of kidney cancer (a review) of different histological types of kidney cancer to therapy with tyrosine kinase inhibitors, to sorafenib

The role of Bruton's tyrosine kinase in pathogenesis of chronic spontaneous urticaria and the prospects for the use of new treatment in all three types of cells is regulated via Bruton's tyrosine kinase signalling pathway through Fcε

Hypertension related to the antitumor treatment with angiogenesis inhibitors: An iatrogenic hypertension [Артериальная гипертония как кардиотоксическая реакция на противоопухолевую терапию: что мы знаем о новом виде ятрогенной гипертонии]Tyrosine kinase inhibitors

Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma
tyrosine kinase inhibitors

Страница 1 из 92